Search - tctmd.com

Displaying 1 - 19 of 19

Sort: Relevancy | Date

News Conference News ACC 2026

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

Todd Neale

April 02, 2026

Presentation ACC 2026

IVUS–Guided versus Angiography-Guided PCI in Unprotected Left Main Disease

Presenter: Luca Testa

March 30, 2026

Presentation ACC 2026

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

Presenter: Nicholas Marston

March 30, 2026

Presentation ACC 2026

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

Presenter: Shao-Liang Chen

March 30, 2026

News Conference News ACC 2026

What’s Going to Be Hot at ACC 2026

Michael O'Riordan

March 20, 2026

Presentation ACC 2025

Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies (FLAVOUR II)

Presenter: Jian’an Wang

March 30, 2025

News Conference News ACC 2024

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

Caitlin E. Cox

April 10, 2024

News Conference News ACC 2024

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

L.A. McKeown

April 08, 2024

Presentation ACC 2024

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

Presenter: Young-Guk Ko

April 08, 2024

Presentation ACC 2024

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

Presenter: Seung-Jung Park

April 07, 2024

News Conference News ACC 2023

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Michael O'Riordan

March 06, 2023

Presentation ACC 2023

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Presenter: Annapoorna S. Kini

March 06, 2023

Presentation ACC 2023

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Presenter: Roberto Diletti

March 05, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Conference News ACC 2022

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Michael O'Riordan

April 06, 2022

Presentation ACC 2022

Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis: The FLAVOUR Randomized Clinical Trial

Presenter: Bon-Kwon Koo

April 04, 2022

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

News Conference News ACC 2019

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

Michael O'Riordan

March 21, 2019

News Conference News ACC 2017

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Yael L. Maxwell

March 18, 2017

Advertisement

Two Neutral IVUS Trials in Complex PCI—and One Positive—Spark Debate

IVUS–Guided versus Angiography-Guided PCI in Unprotected Left Main Disease

Essence-TIMI 73b CCTA Trial: Effect of APOC3 Inhibition with Olezarsen on Coronary Atherosclerosis

IVUS or angiography guidance for PCI in complex coronary bifurcation lesions: The DKCRUSH VIII Trial

What’s Going to Be Hot at ACC 2026

Comparison of angiography-derived fractional flow reserve-guided and intravascular ultrasound-guided PCI strategies (FLAVOUR II)

IVUS Benefits Patients Receiving DCBs for Fem-Pop Disease

PREVENT Supports Early PCI for Vulnerable Plaque, With Reductions in MACE

Comparison of IVUS-guided vs. Angiography-guided Angioplasty for the Outcomes of DCB in the Treatment of Femoropopliteal Artery Disease

PREVENT: Preventive PCI versus Medical Therapy Alone for Treatment of Vulnerable Atherosclerotic Coronary Plaques

No Downside to Immediate Complete Revascularization in ACS: BIOVASC

Effect of Evolocumab on Coronary Plaque Characteristics in Stable Coronary Artery Disease: a Multimodality Imaging Study (YELLOW III)

Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses

Comparison Of Fractional Flow Reserve-guided And Intravascular Ultrasound-guided Percutaneous Coronary Intervention In Intermediate Coronary Artery Stenosis: The FLAVOUR Randomized Clinical Trial

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

High Rate of Residual Ischemia After PCI Despite Excellent Angiographic Outcomes: DEFINE-PCI

CARAT: Novel HDL Mimetic Fails to Show Benefit in Coronary Atherosclerosis After ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content